Maternal-fetal cholesterol transport in the placenta: Good, bad, and target for modulation

Circulation Research

Volumn 104, Issue 5, 2009, Pages 569-571

  Palinski, Wulf ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arteriosclerosis; Cholesterol transport; Developmental programming; Endothelial cells; Placenta

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN B; CHOLESTEROL; LIPOPROTEIN; LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; OXYSTEROL; SCAVENGER RECEPTOR A; ABC TRANSPORTER; ABCG1 PROTEIN, HUMAN; APOLIPOPROTEIN A1; CELL RECEPTOR; DNA BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN 3;

CELL MEMBRANE; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; EDITORIAL; FETUS CIRCULATION; FETUS GROWTH; MOTHER FETUS RELATIONSHIP; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN; ENDOTHELIUM CELL; FEMALE; FETOMATERNAL TRANSFUSION; FETUS BLOOD; HUMAN; HYPERCHOLESTEROLEMIA; METABOLISM; NOTE; PREGNANCY; VASCULARIZATION;

APOLIPOPROTEIN A-I; ATP-BINDING CASSETTE TRANSPORTERS; CELL MEMBRANE; CHOLESTEROL; DNA-BINDING PROTEINS; ENDOTHELIAL CELLS; FEMALE; FETAL BLOOD; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS, HDL3; MATERNAL-FETAL EXCHANGE; PLACENTA; PREGNANCY; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 63649151908     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.109.194191     Document Type: Editorial

References (18)

1. Parker CR Jr, Deahl T, Drewry P, Hankins G. Analysis of the potential for transfer of lipoprotein-cholesterol across the human placenta. Early Hum Dev. 1983;8:289-295.
2. Madsen EM, Lindegaard ML, Andersen CB, Damm P, Nielsen LB. Human placenta secretes apolipoprotein B-100-containing lipoproteins. J Biol Chem. 2004;279:55271-55276.
3. Tint GS, Irons M, Elias ER, Batta AK, Frieden R, Chen TS, Salen G. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med. 1994;330:107-113.
4. Napoli C, D'Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, Palinski W. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997;100:2680-2690.
5. Napoli C, Glass CK, Witztum JL, Deutsch R, D'Armiento FP, Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet. 1999;354:1234-1241.
6. Palinski W, D'Armiento FP, Witztum JL, de Nigris F, Casanada F, Condorelli M, Silvestre M, Napoli C. Maternal hypercholesterolemia and treatment during pregnancy influence the long-term progression of atherosclerosis in offspring of rabbits. Circ Res. 2001;89:991-996.
7. Woollett LA. The origins and roles of cholesterol and fatty acids in the fetus. Curr Opin Lipidol. 2001;12:305-312.
8. Woollett LA. Maternal cholesterol in fetal development: Transport of cholesterol from the maternal to the fetal circulation. Am J Clin Nutr. 2005;82:1155-1161.
9. Stefulj J, Panzenboeck U, Becker T, Hirschmugl B, Schweinzer C, Lang I, Marsche G, Sadjak A, Lang U, Desoye G, Wadsack C. Human endo-thelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1. Circ Res. 2009;104:600-608.
10. Barish GD, Narkar VA, Evans RM. PPAR delta: a dagger in the heart of the metabolic syndrome. J Clin Invest. 2006;116:590-597.
11. Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK, Evans RM, Tontonoz P. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell. 2001;7:161-171.
12. Joseph SB, McKilligin E, Pei L, Watson MA, Collins AR, Laffitte BA, Chen M, Noh G, Goodman J, Hagger GN, Tran J, Tippin TK, Wang X, Lusis AJ, Hsueh WA, Law RE, Collins JL, Willson TM, Tontonoz P. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci U S A. 2002;99:7604-7609.
13. Elias ER, Irons MB, Hurley AD, Tint GS, Salen G. Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS). Am J Med Genet. 1997;68:305-310.
14. Napoli C, Witztum JL, Calara F, de Nigris F, Palinski W. Maternal hypercholesterolemia enhances atherogenesis in normocholesterolemic rabbits, which is inhibited by antioxidant or lipid-lowering intervention during pregnancy: An experimental model of atherogenic mechanisms in human fetuses. Circ Res. 2000;87:946-952.
15. Liguori A, D'Armiento FP, Palagiano A, Balestrieri ML, Williams-Ignarro S, de Nigris F, Lerman LO, D'Amora M, Rienzo M, Fiorito C, Ignarro LJ, Palinski W, Napoli C. Effect of gestational hypercholester-olaemia on omental vasoreactivity, placental enzyme activity and trans-placental passage of normal and oxidised fatty acids. BJOG. 2007;114: 1547-1556.
16. Poston L. Influences of maternal nutritional status on vascular function in the offspring. Curr Drug Targets. 2007;8:914-922.
17. Palinski W, Napoli C. Impaired fetal growth, cardiovascular disease, and the need to move on. Circulation. 2008;117:341-343.
18. Yamashita T, Freigang S, Eberle C, Pattison J, Gupta S, Napoli C, Palinski W. Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring. Circ Res. 2006;99:e51-e64.